HOME >> BIOLOGY >> NEWS
First glimpse of DNA binding to viral enzyme

UPTON, NY -- Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and the Albert Einstein College of Medicine have produced the first molecular-scale images of DNA binding to an adenovirus enzyme -- a step they believe is essential for the virus to cause infection. The images, which appear on the cover of the October 2004 issue of Molecular and Cellular Proteomics, show how binding to DNA may stimulate the enzyme and are already being used to design new antiviral drugs to block this interaction.

"We were quite surprised to see that DNA actually stimulated the activity of the enzyme," said Brookhaven biologist Walter Mangel, a co-author on the paper. "If we can block this interaction, we should be able to prevent the virus from replicating, and thereby thwart infection."

Adenoviruses cause respiratory, gastrointestinal, and eye infections, including highly contagious viral pink eye. Some adenovirus eye infections lead to blindness. Respiratory epidemics of adenovirus are often prevalent on army bases. And in patients with compromised immune systems, such as those infected with human immunodeficiency virus (HIV), an opportunistic adenovirus infection can be deadly.

During infection, adenovirus makes an enzyme called a protease, which cleaves or degrades viral "scaffolding" proteins to complete the maturation of newly synthesized virus particles. Mangel and others have been working to understand all the steps necessary for this enzyme's function, looking for new ways to stop its action and, therefore, block an adenovirus infection (see: http://www.bnl.gov/discover/Spring_04/anti_viral_1.asp).

The scientists didn't expect the viral DNA to bind to the protease, but they figured they should look just to rule out such an interaction. "It was something we had to do, to make sure they did not interact," Mangel said. The discovery that the v
'"/>

Contact: Karen McNulty Walsh
kmcnulty@bnl.gov
631-344-8350
DOE/Brookhaven National Laboratory
13-Sep-2004


Page: 1 2 3

Related biology news :

1. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
2. 2nd media alert First Scientific Conference on Childhood Leukaemia
3. First International Scientific Conference on Childhood Leukaemia
4. First ever standards linking climate change, biodiversity and poverty seek global peer review
5. First genetic comparison of purebred domestic dogs produces surprises
6. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
7. First target for childhood malaria vaccine
8. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
9. First flavors form a lasting impression
10. STN International launches Derwent World Patents Index First View
11. First DFG research conference in the USA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2020)... ... March 25, 2020 , ... ixlayer, an ... address the need to rapidly launch and scale COVID-19 clinical testing. The ixlayer ... deliver, has been adapted for COVID-19 specific content and user flows, allowing physicians/health ...
(Date:3/20/2020)... ... March 20, 2020 , ... ... embryonic stem cell (ESC) derived mesenchymal stem cells (hES-MSC), through a proprietary method ... of neurological, autoimmune, and rare orphan diseases, today announced that the U.S. Food ...
(Date:3/19/2020)... ... March 19, 2020 , ... The former Jason "Furious" ... host to the informational show "In Depth". The TV program highlights a large variety ... shifting gears on a new episode with a dive into the world of applied ...
Breaking Biology News(10 mins):
(Date:3/19/2020)... ... 18, 2020 , ... Family counsellors, marriage/couples therapists, and those ... into their perceptions of events. Imagine if a couple’s counsellor could see the ... measure the level of engagement of each individual in the therapeutic process, then ...
(Date:3/10/2020)... ... March 10, 2020 , ... Lifecycle Biotechnologies announced today that is ... to be used as a biopharmaceutical and biotechnology production and development campus. Lifecycle is ... well as its production and development hub. The company expects to relocate from Fort ...
(Date:3/2/2020)... Md. (PRWEB) , ... March 02, 2020 , ... McBee, ... Patent Firms 2019 list in the field of Biotechnology and Organics. , According to ... on a total of 259 patents issued in technology center 1600 during 2019. Technology ...
(Date:2/21/2020)... , ... February 20, 2020 , ... ... supply chain transparency and reassuring consumers that what’s listed on an ingredient panel ... ingredients, Nutrition21 has introduced this solution with the adoption of CertainT, which is ...
Breaking Biology Technology:
Cached News: